FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity

Commun Biol. 2020 Aug 17;3(1):448. doi: 10.1038/s42003-020-01161-3.

Abstract

Polo like kinase 4 (Plk4) is a tightly regulated serine threonine kinase that governs centriole duplication. Increased Plk4 expression, which is a feature of many common human cancers, causes centriole overduplication, mitotic irregularities, and chromosomal instability. Plk4 can also promote cancer invasion and metastasis through regulation of the actin cytoskeleton. Herein we demonstrate physical interaction of Plk4 with FAM46C/TENT5C, a conserved protein of unknown function until recently. FAM46C localizes to centrioles, inhibits Plk4 kinase activity, and suppresses Plk4-induced centriole duplication. Interference with Plk4 function by FAM46C was independent of the latter's nucleotidyl transferase activity. In addition, FAM46C restrained cancer cell invasion and suppressed MDA MB-435 cancer growth in a xenograft model, opposing the effect of Plk4. We demonstrate loss of FAM46C in patient-derived colorectal cancer tumor tissue that becomes more profound with advanced clinical stage. These results implicate FAM46C as a tumor suppressor that acts by inhibiting Plk4 activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Centrioles / metabolism
  • Colorectal Neoplasms / pathology
  • Conserved Sequence
  • Genes, Tumor Suppressor*
  • Humans
  • Mice, Nude
  • Nucleotidyltransferases / metabolism*
  • Phosphorylation
  • Protein Binding
  • Protein Domains
  • Protein Serine-Threonine Kinases / chemistry
  • Protein Serine-Threonine Kinases / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • PLK4 protein, human
  • Protein Serine-Threonine Kinases
  • Nucleotidyltransferases
  • TENT5C protein, human